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Abstract – Antibody-mediated targeting of antigen to speciﬁc antigen presenting cells (APC) receptors is
an attractive strategy to enhance T cell immune responses to weak immunogenic antigens. Here, we describe
the characterization of two monoclonal antibodies (mAb) against different epitopes of porcine sialoadhesin
(Sn) and evaluate in vitro the potential of targeting this receptor for delivery of antigens to APC for T cell
stimulation. The speciﬁcity of these mAb was determined by amino acid sequence analysis of peptides
derived from the afﬁnity puriﬁed antigen. Porcine Sn is expressed by macrophages present in the border
between white and red pulp of the spleen and in the subcapsular sinus of lymph nodes, an appropriate
location for trapping blood and lymph-borne antigens. It is also expressed by alveolar macrophages
and monocyte-derived dendritic cells (MoDC). Blood monocytes are negative for this molecule, but its
expression can be induced by treatment with IFN-. MAb bound to Sn is rapidly endocytosed. MAb to
sialoadhesin induced in vitro T cell proliferation at concentrations 100-fold lower than the non-targeting
control mAb when using T lymphocytes from pigs immunized with mouse immunoglobulins as responder
cells and IFN- treated monocytes or MoDC as APC, suggesting a role of sialoadhesin in antigen uptake
and/or delivery into the presentation pathway in APC.
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1. INTRODUCTION
Sialoadhesin (Sn), also known as CD169
or Siglec-1, is a membrane protein, mem-
ber of the family of sialic acid binding
immunoglobulin-like lectins (Siglec), which
contains 17 Ig-like domains in its extracel-
lular region, with the sialic acid binding
region localized within the membrane-
distal domain [33]. This molecule is mainly
expressed by speciﬁc subpopulations of tissue
macrophages [9, 13, 16, 21]. Some dendritic
cells (DC) located in lymph nodes [1],
monocytes during inﬂammatory processes
[21, 36], and in vitro monocytes-derived
DC (MoDC) [27] have also been shown to
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express this molecule. Cytokines and growth
factors regulate Sn expression, although
remarkable differences have been reported
between species [21, 30, 41]. Recently, it
has been shown that IFN- induces Sn
expression in porcine monocytes and alveolar
macrophages [14].
Unlike other members of the Siglec
family that mediate inhibitory functions,
Sn lacks immunoreceptor tyrosine-based
inhibitory motifs (ITIM) in its short cyto-
plasmic tail [12]. It appears to function
as a macrophage accessory molecule in a
variety of cell to cell and cell to extracellular
matrix interactions [10, 33]. Preliminary
studies suggest a role of this molecule in
myelopoiesis [10, 11]. However, more recent
data obtained from Sn knockout mice support
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a role for this receptor in the modulation of
inﬂammatory and immune responses [23,34].
Sn is involved in the uptake of different
pathogens in a sialic acid dependent man-
ner [25, 31]. In swine, it has been shown to
play a role as an endocytic receptor in the
attachment and entry of Porcine Reproductive
and Respiratory Syndrome Virus (PRRSV)
in alveolar macrophages [42], with its N-
terminal domain identiﬁed as the virus binding
domain [15].
Targeting of antigens to antigen presenting
cells (APC) by fusing them to mAb that
recognize receptors expressed on these cells,
represents an attractive strategy to enhance the
immunogenicity of weak immunogenic anti-
gens.Avarietyofreceptorshavebeensuccess-
fully evaluated in the murine model for target-
ing antigens [39]. However, only a few reports,
mostly based on the use of ligands to CD40
or CD80/86, describe the use of this strategy
in domestic livestock species [7,18,29,38].
In this study we describe two mAb to
porcine Sn and analyze the expression of
this molecule in porcine tissues, its regulation
by cytokines and its potential as an antigen
targeting receptor. Porcine Sn is expressed in
some subsets of tissue macrophages and in
MoDC. Blood monocytes do not express this
molecule but it can be induced by IFN-.
To explore if antigen targeting to Sn leads
to an enhancement of T cell responses, we
immunized pigs with mouse Ig and used either
IFN- treated monocytes or MoDC as APC,
to compare in vitro the T cell proliferative
response elicited by our mAb to Sn with that
of control mAb. Both mAb to Sn induced T
cell proliferation at concentrations 100-fold
lower than control mAb, suggesting a role of
Sn in antigen uptake and/or delivery to the Ag
presentation pathway. Altogether these results
provide a novel antigen targeting strategy for
direct in vivo evaluation.
2. MATERIALS AND METHODS
2.1. Animals and cells
Large-White outbred pigs were used as cell
donors. Peripheral blood mononuclear cells
(PBMC) and granulocytes were isolated as
described [20]. Porcine alveolar macrophages
were collected by alveolar lavage with PBS [3].
Cells were resuspended in RPMI 1640 medium
containing 10% foetal calf serum (FCS), 2mM
L-glutamine, 5 × 10−5 M 2-mercaptoethanol and
30g/mL gentamicin (complete medium).
Four-month old pigs (n = 4) were immunized
i.m. 3 times at 3 week intervals with 1mg of a
pool of mouse Ig (Sigma, St. Louis, MO, USA),
ﬁrst in complete Freund adjuvant and for the two
subsequent immunizations in incomplete adjuvant.
The reported experiments were executed in
full compliance with guidelines by the ethical
committee of the Institute.
2.2. Antibodies
The hybridoma secreting anti-Sn mAb 1F1 was
derivedfromafusionofspleencellsfromaBALB/c
mouse immunized with porcine MoDC with SP2/0
myeloma cells, using established protocols [28].
Generation of 3B11 mAb secreting hybridoma has
been previously reported [4].
Isotypes of mAb were determined by ELISA,
using rabbit anti mouse heavy and light chain
antisera and a peroxidase-conjugated goat anti-
rabbit Ig (Bio-Rad, Hercules, CA, USA). 3B11 and
1F1 mAb were of IgG1,g  and IgG2a,  isotypes
respectively. For labeling, mAb were puriﬁed from
supernatant by afﬁnity chromatography on Protein
G-Sepharose CL4B (Pharmacia, Uppsala, Sweden).
Biotinylationof mAbwas performedusingstandard
protocols; mAb were labeled with Alexa Fluor
488 dye following the manufacturer’s protocol
(Molecular Probes, Carlsbad, CA, USA).
MAb to CD3 (BB23-8E, IgG2b) was kindly
provided by M. Pescovitz (Indiana University,
Indianapolis, IN, USA), to CD8 (76-2-11, IgG2a)
by J. Lunney (USDA, Beltsville, MD, USA) and
to CD11R1 (MIL-4, IgG1) by K. Haverson (Univ-
ersity of Bristol, Bristol, UK).
MAb to porcine CD172a (BL1H7, IgG1),
CD45RA (3C3/9, IgG1), SLAIIDR (1F12, IgG2b)
and CD11R3 (2F4/11, IGg1) were produced in our
laboratory.
2.3. Flow cytometry
For single staining, cells were incubated with
hybridoma supernatants for 30min at 4 ◦C. After
two washes in FACS buffer (PBS containing
0.1% BSA and 0.01% sodium azide), cells were
incubated with FITC-conjugated rabbit (Fab’)2
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anti-mouse Ig (Dako, Glostrup, Denmark). Subse-
quently, cells were washed twice and then ﬁxed in
0.1% formaldehyde prior to analysis on the cytome-
ter.Irrelevantisotype-matchedantibodieswereused
as controls. Ten thousand cells were acquired.
In cross-blocking experiments, alveolar
macrophages were incubated 20min at 4 ◦C
with 1F1, 3B11 or irrelevant mAb supernatants.
Thereafter, the biotinylated 3B11, Alexa 488 1F1
or irrelevant mAb were added for an additional
20min. Cells were washed and the biotinylated
mAb were developed with streptavidin-PE. Then,
they were ﬁxed in 0.1% formaldehyde and ana-





Tissues were snap frozen in isopentane/liquid
nitrogen and stored at −70 ◦C. Frozen sections of
6m were ﬁxed in cold acetone for 10min and then
washed with PBS.
For immunohistochemical analyses, sections
were stained with monoclonal antibodies by an
indirect immunoperoxidase technique, as previ-
ously described [17]. Brieﬂy, frozen sections were
incubated for 90min at room temperature with
hybridoma supernatants. After washing in PBS,
sections were incubated with a 1/40 dilution of
a polyclonal rabbit anti-mouse Ig conjugated with
peroxidase (Dako) for 60min. After extensive
washing with PBS, sections were incubated for
5min in a solution of 0.6mg/mL diaminobenzi-
dine (Sigma) and 0.02% hydrogen peroxide in PBS.
Finally, they were washed with water, counter-
stained with hematoxilin, dehydrated and mounted
with DePex (Serva, Heidelberg, Germany).
Forimmunoﬂuorescence analyses,sectionswere
blocked 20min with 10% normal goat serum
and incubated 60min at room temperature with
primary monoclonal antibodies. After washing in
PBS, sections were incubated for 60min with
a polyclonal goat anti-mouse Ig conjugated with
Rhodamine Red-X (Molecular Probes). Tissue
sections were washed and blocked 30min with
10% normal mouse serum, and then they were
stained with Alexa 488 labeled 1F1 mAb in the
presence of 5% normal mouse serum. Finally,
sections were washed with PBS and mounted with
FluorSave (Calbiochem, San Diego, CA, USA).
Slides were examined on a Leica DM IRE2
confocal microscope (Heidelberg, Germany).
2.5. Western blotting
Alveolar macrophages (5 × 107)w e r ew a s h e d
twice with PBS and solubilized in 0.5mL lysis
buffer (10mM Tris-HCl, 150mM NaCl, 1mM
EDTA, 1% NP40, pH 7.4, 1mg/mL BSA, 1mM
PMSF and 10g/mL aprotinin) for 1h at 4 ◦C.
After centrifugation at 12000 g for 30min, the
supernatant was mixed with the sample buffer, and
run on a 7.5% SDS-PAGE gel under reducing and
non-reducing conditions. The separated proteins
were transferredtonitrocellulose. Freebinding sites
on nitrocellulose were blocked with PBS-2% BSA.
Thereafter,nitrocellulosestripswereincubatedwith
hybridoma supernatants for 1h at room tempera-
ture, followed by 1h incubation with a peroxidase-
labeled rabbit anti-mouse Ig (Dako). Peroxidase
activity was visualized using the ECL detection
assay (Amersham, Buckinghamshire, UK).
2.6. Immunoprecipitation analysis
Alveolar macrophages (5 × 107)w e r ew a s h e d
three times in PBS and resuspended in 5mL PBS.
Sulfo-NHS-biotin (Pierce, Rockford, IL, USA)
(0.4mg/mL, ﬁnal concentration) was added to
the cells and incubated for 15min at 4 ◦C. After
washing three times with PBS, cells were lysed
with 0.5mL lysis buffer. The lysate was pre-cleared
twice with 50L 25% (v/v) suspension of protein
G-Sepharose (Pharmacia) in lysis buffer, and then
incubated with the different mAb. Three hundred
L of hybridoma supernatant were added to 100L
lysate and incubated for 2h at room temperature.
Then, 40L 25% (v/v) suspension of protein G-
Sepharose was added and incubated for 1h with
gentle mixing. Beads were washed three times
with lysis buffer, boiled in electrophoresis sample
buffer under reducing and non reducing conditions,
and the supernatants were run on a 7.5% SDS-
PAGE and transferred to nitrocellulose. Filters were
incubated with streptavidin-peroxidase (Pierce) and
the bands visualized with the ECL detection assay
(Amersham).
2.7. Puriﬁcation and partial sequence analysis
of 3B11 antigen
Twelve mg of mAb 3B11 were coupled
to 2.5mL CNBr-activated Sepharose 4B beads
(Pharmacia), according to the indications of the
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manufacturer. Alveolar macrophage lysates were
obtained from 1 × 109 cells. Lysis was performed
at 108 cells/mL for 1h at 4 ◦C, in 1% Nonidet
P-40, 50mM Tris pH 8, 150mM NaCl, 5mM
EDTA, 0.1mM PMSF, 10g/mL aprotinin and
10mM iodacetamide. Lysates were precleared by
incubation for 24h with normal mouse IgG-coupled
Sepharose beads. Precleared lysates were incubated
for an additional 24h with 3B11 mAb-coupled
beads. After that, beads were washed several times
with the buffer used for lysis and ﬁnally with PBS.
The adsorbed fraction was eluted from the beads
by adding 50mM diethylamine pH 11. The eluted
fraction was dialyzed against 10mM ammonium
bicarbonate pH 8, concentrated by lyophilization
and subjected to 7.5% SDS-PAGE. The main band,
with an apparent molecular weight of 190kDa, was
excised and digested with trypsin. The resulting
peptides were separated by HPLC, and subjected to
Edman degradation on an Applied Biosystem 473-
A pulse liquid phase protein sequencer (Applied
Biosystem, Carlsbad, CA, USA). Peptide identities
were searched on SwisProt, EMBL and GeneBank
databases, using the Blast analysis program1.
2.8. Monocyte isolation and culture conditions
Monocytes were isolated from PBMC using the
magnetic cell separation system of Miltenyi Biotec
(Bergisch Gladbach, Germany). First, PBMC were
incubated with an antibody cocktail containing
anti-CD3, anti-CD45RA and anti-CD8, and after
30min at 4 ◦C washed with PBS containing 5%
FCS and 2mM EDTA. Subsequently, anti-mouse Ig
magnetic microbeads were added and incubated for
15min on ice. Then, cells were washed and passed
through a MACS CS separation column (negative
selection). The efﬂuent fraction was collected and
analyzedbyﬂowcytometryresultingin90%pure
population according to the expression of CD172a.
Freshly isolated monocytes were cultured at
2.5 × 106 cells/mL in complete medium with
different stimuli or in medium alone for 24
or 48h. Porcine recombinant IFN- (400U/mL)
and IFN- (0.8U/mL) were generously provided
by F. Lefevre (INRA, France); recombinant
porcine IL10 (50ng/mL), IL4 (50ng/mL) and GM-
CSF (50ng/mL) were obtained from BioSource
(Carlsbad, CA, USA); porcine serum (20%) was
1 http://blast.ncbi.nlm.nih.gov
purchased from Harlan Sera-Lab (Leicestershire,
UK). After culture, cells were harvested, stained as
indicated and analyzed by ﬂow cytometry.
For differentiation of blood monocytes into DC,
monocytes were cultured in complete medium
supplemented with recombinant porcine IL4
(50ng/mL), GM-CSF (50ng/mL) and IFN-
(0.8U/mL) for 7 days as described for human and
porcine cells [24,35].
2.9. Internalization assay
Alveolar macrophages were incubated with
Alexa 488-labeled 1F1 mAb for 30min at 4 ◦C,
without azide. After washing, cells were cultured
at 37 ◦C for different times, and then treated or left
untreated with a buffer containing 0.5% acetic acid,
0.5M NaCl pH 2.8 (low pH buffer) for 15 s to
disrupt the surface mAb-Sn interactions. We used
cells labeled with 1F1 mAb at 4 ◦C in the presence
of 0.01% azide, and then treated or not with the
low pH buffer as controls. Subsequently, the cells
were washed, ﬁxed in 0.1% formaldehyde and
analyzed in the cytometer. An irrelevant isotype-
matched Alexa Fluor 488 labeled mAb was used to
determine background staining.
2.10. T cell proliferation assay
For proliferation assays, 2 × 105 T cells, enri-
ched from PBMC by passing through a nylon wool
column (Polysciences, Warrington, PA, USA), were
mixed with monocytes cultured 24h with IFN- or
MoDC and incubated with different concentrations
of anti-Sn or control mAb. Cultures were run
for 4 days at 37 ◦C with 5% CO2,t h e n1 Ci
3H-thymidine was added per well and 18h later
cells were harvested and 3H-thymidine uptake was
measured by liquid scintillation counting.
3. RESULTS
3.1. Monoclonal antibodies 3B11 and 1F1
recognize porcine Sn
Hybridomas producing mAb 3B11 and 1F1
were derived from two independent fusions
using as immunogen either porcine alveo-
lar macrophages or MoDC respectively. Both
mAb reacted with alveolar macrophages and
MoDC, while blood lymphocytes, monocytes
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Figure 1. (A) MAb 1F1 and 3B11 recognize an antigen expressed in alveolar macrophages and MoDC.
Cells were labeled with 1F1 or 3B11 mAb (black histograms) or with irrelevant isotype-matched mAb (grey
histograms). Results are representative of ﬁve independent experiments. (B) In the spleen, staining with 1F1
(1) and 3B11 (2) mAb appears associated with the walls of the ellipsoidal vessels that surround the islands
of white pulp. (C) In lymph nodes, the antigen was detected in the subcapsular sinus and medullary cords
(1) and in the periphery of follicles and some follicular cells (2). (A color version of this ﬁgure is available
at www.vetres.org.)
and granulocytes were not stained (Fig. 1A).
Tissue distribution of the antigen recognized
by these mAb was analyzed by immunohis-
tochemical staining of different tissues. The
pattern of staining was similar for both mAb.
In the spleen, the staining appeared mainly
located in the border between white and red
pulp and associated with the walls of the
ellipsoidal vessels (Fig. 1B). In lymph nodes,
the antigen was detected in subcapsular and
medullary sinuses, but also in the periphery
of follicles, with some positive cells inside the
follicles (Fig. 1C).
Two-color immunoﬂuorescence analysis
by confocal microscopy of frozen sections
showed that in the spleen (Figs. 2a–2c)
and lymph nodes (Figs. 2d, 2e), most
1F1+ cells expressed the myeloid marker
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Figure 2. Double staining of spleen (a–c) and mediastinal lymph node (d,e) sections was carried out with
1F1 mAb and mAb to CD172a (a, d), SLAII (b, e) and CD11R1 (c). Arrows point to representative cells
co-expressing the indicated markers in the border between white and red pulp of the spleen, and in the
subcapsular sinus of lymph nodes.
P a g e6o f1 5( page number not for citation purpose)Targeting antigen to sialoadhesin Vet. Res. (2009) 40:14
IMMUNOPRECIPITATION
Figure 3. Biochemical characterization of antigen recognized by 1F1 and 3B11 mAbs. (A) Lysates from
biotin-labeled alveolar macrophages were immunoprecipitated with 1F1 mAb or an irrelevant isotype-
matched control mAb (Con) and analyzed by 7.5% SDS-PAGE under reducing and non-reducing conditions.
Numbers in the right indicate position where MW markers ran. (B) Detection by western-blotting of
the 1F1 and 3B11 antigens on alveolar macrophage extracts subjected to 7.5% SDS-PAGE under non-
reducing conditions. (C) Immunoprecipitation analysis after preclearing. Lysates from biotin-labeled
alveolar macrophages were immunoprecipitated with mAb 1F1 and 3B11 after preclearing twice with the
mAb indicated in the table. Arrow points the speciﬁc band, numbers in the left indicate position where MW
markers ran. Results are representative of three independent experiments.
CD172a. SLAII molecules were clearly
expressed on a subset of 1F1+ cells. In the
spleen a minor proportion of 1F1+ cells also
expressed CD11R1, a marker that has been
associated with tissue DC.
MAb 3B11 was previously shown to
recognize a single protein that migrates
around 204kDa in SDS-PAGE under reducing
conditions. Mab 1F1 precipitated, from lysates
of biotin-labeled alveolar macrophages, a
single protein of about 190kDa under non-
reducing conditions, which became about
204kDa under reducing conditions in SDS-
PAGE (Fig. 3A). Western blotting on alveolar
macrophage lysates shows that both 1F1 and
3B11 mAb recognize a band of about 190kDa
under non-reducing conditions (Fig. 3B). All
these data suggest that both mAb react
with the same antigen; to conﬁrm this,
alveolar macrophage lysates were pre-cleared
with either 1F1 or 3B11 mAb followed by
immunoprecipitation with the other mAb. As
shown in Figure 3C, clearance of lysates with
1F1 removed the band precipitated by 3B11,
and clearance with 3B11 mAb resulted in the
removal of the band brought down by 1F1
mAb, establishing that these mAb recognize
the same molecule.
To determine whether 1F1 and 3B11
mAb recognize the same epitope, cross-
blocking experiments were carried out. 1F1
mAb competitively blocked the binding of
labeled 1F1 but not that of 3B11 to
alveolar macrophages, as determined by ﬂow
cytometric analysis (Fig. 4). Likewise, 3B11
blocked the binding of labeled 3B11 but not
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Figure 4. MAb 1F1 and 3B11 bind to two different epitopes on the Sn molecule. Black histograms show
binding of labeled 3B11 or 1F1 mAb on alveolar macrophages after incubation with the indicated unlabeled
antibodies. Grey histograms correspond to the negative control staining. Results are representative of at least
two independent experiments using cells from different animals.
that of labeled 1F1. Altogether, these results
indicate that 3B11 and 1F1 mAb react with
different epitopes on the same molecule.
To identify the molecule recognized by
3B11 and 1F1 mAb, it was puriﬁed from
alveolar macrophage lysates by afﬁnity
chromatography on a column of 3B11
mAb-coupled Sepharose, and subjected to
SDS-PAGE. The 190kDa band was cut
out, digested with trypsin, and the resultant
peptides resolved by HLPC and subjected to
protein micro sequencing. Sequences from
three tryptic peptides of the antigen were
obtained (Tab. I). Computer searching of
SwisProt, EMBL, and GeneBank databases1
showed that peptides were identical to those
of pig Sn (see Tab. I). Only Sn from other
species showed a signiﬁcant homology to the
swine 3B11 antigen peptides.
3.2. Regulation of Sn expression on monocytes
by cytokines or porcine serum
Swine blood monocytes were magnetically
isolated and cultured for 24 or 48h in the
presence of different stimuli or in medium
Table I. Comparison of partial peptide sequences between 3B11 Ag and porcine Sn.
Peptide Sequence Identity (%)
Peptide 1 PLQESTSATLR
Porcine Sn 928 WYRDGQPLQESTSATLRIAAI 948 100
Peptide 2 DLQPQDSGSYNFR
Porcine Sn 101 LLKDLQPQDSGSYNFRFEIS 119 100
Peptide 3 VNSDPPAQLR
Porcine Sn 998 LGLLLCRVNSDPPAQLRLLH 1018 100
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alone. After 24h in culture with IFN-
some 80% of cells became positive for the
expression of Sn, and its expression remained
at least for 48h. A lower enhancement of
Sn expression was also achieved by culturing
monocytes with porcine serum (30–40% of
positive cells). On the contrary, medium alone,
IL4, IL10 or IFN- did not cause a signiﬁcant
induction of Sn expression (Fig. 5).
3.3. 1F1 mAb is internalized upon binding
To test the endocytic capacity of Sn,
alveolar macrophages were incubated with
Alexa 488-labeled 1F1 mAb, for 30min at
4 ◦C in FACS buffer without azide. After
washing, cells were incubated at 37 ◦C for 15,
30 or 45min to allow mAb internalization, and
then treated or not for 15s with a dissociating
buffer containing 0.5% acetic acid, 0.5M
NaCl pH 2.8 (low pH buffer) to remove
the antibody bound to the cell surface. Cells
identically treated, but in the presence of
azide to prevent internalization, were used
as controls. As shown in Figure 6, mAb
to Sn was rapidly internalized. After 15min
of incubation at 37 ◦C, about 30% of the
cells remained stained with the Alexa 488-
labeled 1F1 mAb after treatment with the low
pH buffer, and the amount of ﬂuorescence
located inside the cells increased for 45min.
In contrast, in the presence of azide no
ﬂuorescence was detected after treatment with
the low pH buffer. These results indicate
that 1F1 mAb was signiﬁcantly and rapidly
endocytosed by alveolar macrophages upon
binding to Sn.
3.4. Targeting to Sn enhances T cell immune
response
Taking into account that Sn is an endocytic
receptor expressed on APC, we wondered if
antigen delivery to this receptor using the 1F1
mAb as an Ag surrogate, could lead to a more
efﬁcient antigen presentation and generation
of an antigen-speciﬁc T cell response. Pigs
were immunized with a pool of mouse Ig and
T cell proliferative response induced by anti-
Sn mAb 1F1 analyzed in vitro, and compared
with that induced by an isotype-matched
irrelevant mAb. When MoDC were used as
APC, anti-Sn mAb induced proliferation of
T cells at concentrations 100-fold lower than
the non-targeting control mAb. Under these
conditions, as few as 0.02g/mL of 1F1
mAb induced a response equivalent to that
of 2g/mL of the control mAb, as measured
by 3H-thymidine uptake (10593 ± 731cpm
versus 7414 ± 681cpm) (Fig. 7A). A similar
result was obtained when monocytes cultured
with IFN- were used as APC. In this case
1g of isotype-matched control mAb was
needed to get a similar T cell response
to that obtained with 0.01g of mAb 1F1
(6969 ± 1334cpm versus 6937 ± 970cpm)
(Fig. 7B). Similar results were obtained with
mAb 3B11, whereas no proliferation was
observed when cells from non immunized
animals were treated with anti-Sn mAb (data
not shown). These results indicate an efﬁcient
role of Sn in antigen uptake and/or processing
in APC.
4. DISCUSSION
In this study we report the characterization
of two mAb, 1F1 and 3B11, that react with
porcine Sn. Conﬁrmation of the speciﬁcity
of these mAb comes from the sequence
analysis of peptides derived from the antigen
recognized by them.
The distribution of Sn on porcine leukocyte
populations is close to that reported in
humans [21, 37], being detected on subsets
of macrophages mostly located in the border
region between the white and red pulp
and in the walls of sheathed capillaries or
ellipsoids in the spleen, sinuses and periphery
of follicles in lymph nodes, and Kupffer
cells of the liver [4]. Moreover, like in
humans [27], porcine MoDC express Sn. We
also detected a subpopulation of Sn-positive
cells within lymph node follicles that could
be related to the DC described in mice
that have the capacity to attract and provide
antigenic stimulation to lymphocytes [1].
Porcine Sn is highly expressed in alveolar
macrophages and, at low levels, in bone
marrow macrophages [19]; in contrast, rat
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Figure 5. Regulation of Sn expression on blood monocytes by cytokines or porcine serum. Black histograms
show the staining with 1F1 mAb on monocytes subjected to the indicated stimuli after 24 or 48 h.
Grey histograms show binding of an irrelevant isotype-matched mAb. Results are representative of ﬁve
independent experiments.
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Figure 6. Anti-Sn mAb 1F1 is efﬁciently internalized in alveolar macrophages upon binding. Black
histograms show 1F1- Alexa 488 ﬂuorescence associated to the cells after treatments and 37 ◦C incubation
times indicated in the ﬁgure. Cells labeled with 1F1 mAb at 4 ◦C in the presence of azide to block
endocytosis, either untreated (maximum binding) or treated (background binding) with the low pH buffer
were used as controls. Grey histograms show binding of an isotype-matched control mAb. Results are
representative of three independent experiments.
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mAb (µg/mL)
Figure 7. Antigen targeting to Sn enhances T cell immune responses. 3H-thymidine incorporation (cpm) in
T cells from pigs immunized with mouse Ig, stimulated with 1F1 mAb (black) or an isotype-matched control
mAb (grey) at the indicated concentrations, using as APC: (A) MoDC or (B) Monocytes treated with IFN-
for 24h. The results are representative of three independent experiments.
and mouse alveolar macrophages are nearly
negative for Sn, while bone marrow resident
macrophages are clearly positive [8,41]. This
is not an unexpected ﬁnding since important
differences have been reported among species
in the regulation of Sn expression by
cytokines, serum factors or glucocorticoids
[8, 21, 30, 41]. We show here that, like in
humans and mice [9, 21], porcine monocytes
do not express Sn, but it can be up regulated
to the levels found on macrophages by treating
these cells with IFN- and, at a lower extent,
by culturing them with porcine serum. These
results agree with those reported by other
authors which have described that IFN-
treatment of porcine monocytes induces the
expression of Sn [14].
Porcine Sn has been involved in the
attachment and entry of PRRSV into alve-
olar macrophages [42]. The attachment of
this virus to Sn is dependent on the
sialic acid-binding activity of the N-terminal
immunoglobulin domain of this receptor, but
other domains might contribute to this interac-
tion [15]. Competitive binding assays indicate
that mAb 1F1 and 3B11 recognize two differ-
ent epitopes on the Sn molecule since they do
not block the binding of each other. Although
further studies are needed to map these epi-
topes in more detail, previous unpublished
work in our laboratory showed that mAb 3B11
can block the in vitro PRRSV infection of
porcine alveolar macrophages. These mAb
may therefore represent a valuable addition
to the limited collection of reagents currently
available for the analysis of PRRSV-cell inter-
actions.
Targeting antigens to receptors expressed
in APC is being evaluated as a strategy to
enhance the immunogenicity of vaccines.
Sn might be a good candidate for targeting
antigens, as long as it is expressed in APC
and has endocytic capacity. Indeed, we show
that a signiﬁcant amount of Alexa 488 labeled
mAb 1F1 was internalized upon binding to
alveolar macrophages. In addition, we see that
a portion of Sn-positive cells in lymph nodes
and spleen co-express SLAII molecules and
therefore they are presumably capable of anti-
gen presentation. A few Sn-positive cells also
express CD11R1, a marker that has been asso-
ciatedtotissueDCinthepig[2,22].Moreover,
the anatomical location of Sn-positive cells in
these organs is suitable for trapping blood and
lymph-borne antigens. In mice, Sn-positive
cells in lymph nodes, spleen and liver are
capable of antigen uptake and presentation
of processed peptides to T cells [1, 32, 40].
Moreover, Sn-positive subcapsular sinus
macrophages in lymph nodes have been
shown to capture particulate antigens, such
as viruses, arriving via the lymph from the
site of infection, and retain them unprocessed
for the efﬁcient presentation and activation of
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follicular B cells, leading to the initiation of
humoral immune responses [6,26].
We took advantage of immunogenicity of
mouseimmunoglobulins (Ig)inpigstosetupa
modelfortheanalysisofthecapacityofmouse
mAb to target antigen. Thus, using T lympho-
cytes from animals that had been immunized
with a pool of mouse Ig as responder cells, and
MoDC or monocytes cultured with IFN- as
APC, we compared, in vitro, the proliferative
response induced by anti-Sn mAb (1F1) with
that of a control mAb. MAb 1F1 induced recall
T cell proliferative responses at concentrations
100-fold lower than a non-targeting control
mAb, indicating that targeting Ag to Sn is
an effective way to increase immunogenicity
of Ag. These data suggest that Sn ligands
efﬁciently gain access to the major histocom-
patibility complex processing and presentation
pathways. Recently, it has been reported that
in vivo targeting Siglec-H, another member
of the Siglec receptor family, is a useful way
for delivering antigens to plasmacytoid DC
precursors for cross-presentation [43]. Sn and
other Siglecs can interact with sialic acids on
different pathogens, increasing their binding
to target cells and contributing to their endo-
cytosis or phagocytosis [5, 15, 25, 31]. The
data presented here agree with the hypothesis
that Siglec-dependent uptake of pathogens
could beneﬁt the host by promoting pathogen
destruction and antigen presentation. Future
in vivo experiments will test the capacity of
antibody mediated targeting of Sn to induce
antigen-speciﬁc primary T cell responses.
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